Psychological burden, subjective complaints and their impact on the progression of verbal fluency in COVID-19 survivors and healthy controls: a longitudinal analysis.
BMC psychology · 2026
Abstract originale
BACKGROUND: This study aimed to investigate the longitudinal change of verbal fluency after COVID-19 and potential influencing factors in a community-based sample. Within the COVIMMUNE-Clin study at the University of Bonn Medical Center, participants with a mild course of COVID-19 (n = 52), a severe course (n = 52), and healthy controls (n = 55) were compared. This focused secondary analysis examined verbal fluency as a distinct cognitive outcome within the broader study. METHODS: Semantic and lexical verbal fluency, assessed using the Vienna Verbal Fluency Test (WIWO), as well as psychological burden measured by the ICD-10 Symptom Rating Scale (ISR) and subjective complaints assessed with the Everyday Cognition-12 (ECog-12) questionnaire, were administered at the first visit and again after 12 months. A linear mixed model was employed, incorporating Group (mild, severe and healthy controls) and Visit as fixed effects, with Subject and the Intercept as random effects. ISR and ECog-12 were each incorporated into separate models as fixed effects. RESULTS: Group and psychological burden had an impact on semantic fluency, in a way that more severe disease and higher psychological burden were associated with lower performance. Contrary to the hypothesis, verbal fluency did not significantly change over 12 months. Across models, verbal fluency types showed distinctive patterns, which is reflected by the fact that psychological burden and subjective complaints only showed an association with semantic fluency performance. Lexical fluency showed no significant effects of these constructs and was primarily positively influenced by education. CONCLUSION: COVID-19 disease severity, psychological burden, and subjective complaints were associated with semantic fluency. These findings support further research on whether verbal fluency measures, in combination with self-reported symptoms, may contribute to practical assessment approaches following COVID-19. TRIAL REGISTRATION: Specific details of the study design are included at the German Clinical Trials Registry (primary registry trial identifier: DRKS00023806; registration date: March 16, 2021, cross-referenced at World Health Organization's International Clinical Trials Registry Platform [ICTRP]).
Parole chiave
Leggi il testo integrale originale
Testo estratto dalla pubblicazione: sono esclusi immagini, media, supplementi e parti soggette a diritti distinti.
Psychological burden, subjective complaints and their impact on the progression of verbal fluency in COVID-19 survivors and healthy controls: a longitudinal analysis
Background
This study aimed to investigate the longitudinal change of verbal fluency after COVID-19 and potential influencing factors in a community-based sample. Within the COVIMMUNE-Clin study at the University of Bonn Medical Center, participants with a mild course of COVID-19 (n = 52), a severe course (n = 52), and healthy controls (n = 55) were compared. This focused secondary analysis examined verbal fluency as a distinct cognitive outcome within the broader study.
Methods
Semantic and lexical verbal fluency, assessed using the Vienna Verbal Fluency Test (WIWO), as well as psychological burden measured by the ICD-10 Symptom Rating Scale (ISR) and subjective complaints assessed with the Everyday Cognition-12 (ECog-12) questionnaire, were administered at the first visit and again after 12 months. A linear mixed model was employed, incorporating Group (mild, severe and healthy controls) and Visit as fixed effects, with Subject and the Intercept as random effects. ISR and ECog-12 were each incorporated into separate models as fixed effects.
Results
Group and psychological burden had an impact on semantic fluency, in a way that more severe disease and higher psychological burden were associated with lower performance. Contrary to the hypothesis, verbal fluency did not significantly change over 12 months. Across models, verbal fluency types showed distinctive patterns, which is reflected by the fact that psychological burden and subjective complaints only showed an association with semantic fluency performance. Lexical fluency showed no significant effects of these constructs and was primarily positively influenced by education.
Conclusion
COVID-19 disease severity, psychological burden, and subjective complaints were associated with semantic fluency. These findings support further research on whether verbal fluency measures, in combination with self-reported symptoms, may contribute to practical assessment approaches following COVID-19.
Trial registration
Specific details of the study design are included at the German Clinical Trials Registry (primary registry trial identifier: DRKS00023806; registration date: March 16, 2021, cross-referenced at World Health Organization’s International Clinical Trials Registry Platform [ICTRP]).
Supplementary Information
The online version contains supplementary material available at https://doi.org/10.1186/s40359-026-05929-w.
Background
The COVID-19 pandemic, caused by the SARS-CoV-2 virus, has significantly affected human health and daily life [1], including cognitive functioning. Various cognitive domains, like (working) memory, verbal fluency, and psychomotor speed, have shown measurable declines following COVID-19 infection [2, 3]. Research indicates that verbal fluency is among the most frequently impaired cognitive functions in post-COVID-19 patients [3–5]. Moreover, difficulties with verbal abilities can reduce an individual’s quality of life [6]. Cognitive problems, particularly in verbal fluency, can persist long after the acute phase of the infection [7, 8]. In fact, Post-COVID syndrome (PCS) encompasses a myriad of lasting symptoms, with fatigue, shortness of breath, and cognitive dysfunction being the most prevalent according to the World Health Organization (WHO) [9].
Early neuropsychological research on COVID-19-related cognitive dysfunction focused largely on possible hippocampal vulnerability and associated memory deficits, commonly assessed using verbal learning and memory tasks [10]. However, research soon also pointed to frontal-executive dysfunction, including deficits in verbal fluency [11]. Crucially, these two measures assess related but distinct cognitive processes, and findings in episodic memory cannot be assumed to generalize to verbal fluency. Beyond cognitive dysfunction, psychological factors also represent significant neuropsychological sequelae of PCS [12]. Studies show that individuals recovering from COVID-19 frequently exhibit increased rates of neuropsychiatric symptoms, including anxiety, posttraumatic stress, and depression, in the short term [13–15] and the long term [16]. Psychological burden has been generally linked to verbal fluency impairments [17] suggesting that it may contribute to the cognitive difficulties observed in COVID-19 survivors. Additionally, high psychological burden is a well-established risk factor for cognitive decline [18–20].
While cognitive and psychological challenges occur at an individual level, they are also shaped by broader factors, including the pandemic itself. Fatigue and cognitive problems following COVID-19 are not solely attributable to biological or physical health; psychological factors, such as mental health, and social determinants, including social support systems, also play crucial roles [21]. The pandemic context has also been linked to increased mental health problems, further underscoring the need to consider broader societal impacts when examining sequelae of COVID-19 [22, 23]. Emotional factors such as increased anxiety, depression, and stress during the COVID-19 pandemic may be particularly relevant in older adults. In this population, emotional state, cognitive functioning, and subjective well-being appear closely interrelated, with higher levels of depressive symptoms being associated with poorer global cognitive performance and reduced life satisfaction [24, 25]. Moreover, although social isolation predated the COVID-19 pandemic, pandemic-related restrictions substantially reduced opportunities for social interaction, which may have further contributed to cognitive decline in older adults [26, 27].
An understanding of cognitive difficulties is further complicated by inconsistent findings regarding the correlation between subjective and objective performance [5, 28]. Psychological distress may further contribute to this discrepancy, as anxiety, depression, and stress can influence both perceived and objectively measured cognitive functioning [29]. Additionally, self-report remains essential in assessing mental abilities when objective measures are unavailable or fail to detect subtle impairments [5]. This dual approach is particularly relevant in the context of PCS, where over one-third of COVID-19 survivors report high levels of subjective cognitive impairment, at least in the short- to medium term [8].
Current explanatory approaches and gaps
Prior research has largely relied on brief, general screenings such as the 10-minute Mini-Mental State Examination (MMSE), merely assessing superficial measures of general cognitive function or self-reports [5]. Additionally, many studies have used clinical convenience samples and lacked contemporaneously recruited healthy control groups [5], making it difficult to distinguish between pandemic-related effects and direct consequences of COVID-19. These methodological limitations restrict a more comprehensive understanding of symptom development over time [30].
Aim and hypotheses
This study aimed to characterize the progression of verbal fluency performance in two distinct cohorts of COVID-19-recovered patients—those with initially mild/asymptomatic (MLD) and severe (SEV) cases—compared to a healthy control group (HC). Participants in all groups (HC, MLD, SEV) were primarily recruited from the community and did not comprise a PCS clinical sample. At the start of the study, PCS was only speculated upon and yet to be identified.
The study spans a 12-month period between Visit 1 (V1) and Visit 3 (V3), allowing for a more in-depth analysis of long-term symptom patterns. The use of detailed verbal fluency assessments allows investigation of whether cognitive differences between groups persist, improve, or diminish over a 12-month period. Verbal fluency tasks are particularly suitable in this context because they can be seen as a proxy of general cognitive functioning and are sensitive to both language-related and executive cognitive dysfunction [31]. They may be influenced by subtle impairments associated with psychological distress and post-viral cognitive complaints [32].
However, semantic (category) and lexical (letter) verbal fluency recruit partially overlapping but distinct neural networks and are therefore examined separately. While both involve the left inferior frontal gyrus, lexical fluency relies more heavily on frontal executive regions, whereas semantic fluency additionally depends on temporal lobe structures involved in semantic processing [31, 33].
Furthermore, this study explores how COVID-19 burden, psychological distress, and subjective cognitive complaints relate to verbal fluency over time. Based on prior findings of greater cognitive impairment following more severe acute COVID-19 disease [34, 35], we expect that the severity of COVID-19 will be linked to verbal ability, with healthy controls performing better than those who had mild/asymptomatic or severe cases. At the first assessment (V1), verbal ability is anticipated to follow the pattern HC > MLD > SEV, and we expect this burden level to influence changes in performance by the final assessment (V3), with SEV participants showing the least improvement.
Psychological burden is another important factor, as high levels of distress have been associated with cognitive difficulties and reduced verbal fluency performance [36, 37]. We predict that greater psychological burden will correlate with lower verbal fluency scores across all groups, with the strongest effects observed in those who experienced severe COVID-19.
Additionally, subjective cognitive complaints—how individuals perceive their cognitive difficulties—may play a role in verbal ability over time. Although associations between subjective complaints and objective cognitive performance in post-COVID populations have been inconsistent, subjective complaints are closely linked to psychological distress and reduced well-being, both of which have been associated with poorer cognitive functioning [38, 39]. Therefore, we expect that participants reporting higher levels of subjective complaints, particularly those in the SEV group, would show less improvement in verbal fluency between V1 and V3. By examining these relationships, this study aims to provide a more comprehensive understanding of how COVID-19 and its psychological effects shape long-term cognitive outcomes.
Method
Setting and procedure
This research uses data from the Long-term consequences of COVID-19 for pulmonary and neurocognitive disorders (COVIMMUNE-Clin) study, a longitudinal prospective cohort study at the University of Bonn Medical Center (UKB). Data collection lasted from April 2021 to February 2023. The primary objective of COVIMMUNE-Clin was to compare neurocognitive and pulmonological outcomes among three distinct groups: mild/asymptomatic (MLD) and severe remitted (SEV) COVID-19-cases, and healthy controls (HC). The interval between the COVID-19 infection and the initial assessment (baseline) for the patient groups varied.
Participants underwent comprehensive evaluations at three different time points: baseline (time of recruitment), six months, and twelve months (visits 1, 2, and 3). However, this analysis focuses on neuropsychological data from the baseline and the 12-month visits (visits 1 and 3). Assessments included detailed neuropsychological testing, neurological examination, lung function tests, MRI scans, and blood sampling for neurodegenerative biomarker analysis.
All neuropsychological assessments were administered by professionally trained and certified psychological raters, as detailed in Widmann et al. [40]. The examinations were conducted using both paper-based and tablet-based formats, the latter utilizing the Vienna Testing System (VTS) software (Wiener Testsystem Version 8.15, Schuhfried, Mödling). The registered primary endpoint of COVIMMUNE-Clin was verbal episodic memory, operationalized as long-delayed verbal recall on the Auditory Verbal Learning Test (AWLT) at Visit 3. The study protocol further pre-specified exploratory analyses of group differences across other cognitive domains, including attention, language, and executive function. The present study constitutes a focused secondary analysis of verbal fluency within this broader neuropsychological assessment. The specific focus on verbal fluency was additionally supported by the clinical relevance of word-finding and verbal-retrieval complaints and the emerging literature on verbal fluency after COVID-19.
Ethical considerations
The study was approved by the internal review board of the University Hospital Bonn (IRB Number 511/20 on 10.03.2021). Specific details of the study design are included at the German Clinical Trials Registry (primary registry trial identifier: DRKS00023806; registration date: March 16, 2021, cross-referenced at World Health Organization’s International Clinical Trials Registry Platform [ICTRP]). All participants gave their informed consent before any test was administered.
Participants
This study aimed to include 150 participants, distributed equally among three groups: severe cases, mild/asymptomatic cases, and healthy controls. An initial over-recruitment strategy was implemented to mitigate potential dropouts and the risk of HC participants contracting COVID-19 during the study.
For the baseline data wave, a total of 159 individuals were included: HC (n = 55), SEV (n = 52), and MLD (n = 52). The general inclusion criteria required individuals aged 25 to 75, proficiency in German, with additional criteria specific to each group. Inclusion and exclusion criteria are detailed in Additional File 1. Various recruitment methods were employed. Two cohorts were contacted via letter: one from the COVID-19 Case Cluster Study (Heinsberg Study), comprising primarily severely affected patients, and another consisting of former in-patients of the UKB treated for COVID-19. A press release generated substantial media coverage in newspapers and on the radio. Additionally, posters of study details and contact information were placed in UKB waiting rooms, and advertisements on the UKB website and social media platforms (Facebook and Instagram managed by the UKB Communications Department). Interested participants underwent systematic telephone screening. As compensation, participants exclusively received free parking.
Measures
Wiener wortflüssigkeitstest – vienna verbal fluency test
The Vienna Verbal Fluency Test (Wiener Wortflüssigkeitstest, WIWO), part of the Vienna Testing System (VTS) for cognitive functions in dementia [41], includes two subtests relevant to this analysis. The first subtest assesses semantic fluency, requiring participants to generate as many words as possible within a given category (e.g., animals). The second subtest assesses lexical fluency, in which participants list words starting with a specific letter (e.g., “S”) while adhering to specific rules (e.g., avoiding repetitions, numbers, and proper nouns). Each subtest has a one-minute time limit, and performance was measured by the total number of correct words produced. The WIWO was selected as it allows standardized, computerized assessment of semantic and lexical verbal fluency, cognitive domains previously reported to be affected following COVID-19 infection. The test demonstrates adequate reliability in a clinical standard sample (Cronbach’s α = 0.75 and 0.71) [41].
International statistical classification of diseases and related health symptom rating
The ICD-10 Symptom Rating scale (ISR) is a 29-item self-assessment questionnaire designed to evaluate level of psychiatric symptoms across multiple disorders, including depression, anxiety, obsessive-compulsion, somatoform and eating disorders, based on ICD-10 criteria [42]. Responses range from 0 (“not applicable”) to 4 (“extremely true”), with the total score reflecting overall symptomatic burden. A threshold score determines clinical relevance for each of these disorders. For this study, the ISR total score and subscales (continuous variables) serve as dependent variables. ISR demonstrates high reliability (Cronbach’s α = 0.87; 26).
Everyday cognition 12
The Everyday Cognition 12 (ECog-12) inventory, adapted for self-assessment in the context of COVID-19, measures cognitive abilities relevant to daily activities. Patients rate their abilities in comparison to their pre-COVID-19 state, while healthy controls use the onset of the pandemic as a reference point [43]. This inventory consists of 12 items, including two that specifically relate to verbal functioning, such as changes in articulating thoughts in conversation. Responses ranged from 1 (“better or no change”) to 4 (“constantly much worse”), with an option of 5 (“I do not know”). The ECog-12 demonstrates excellent reliability (Cronbach’s alpha of 0.96; 27).
Reliable digit span
The Reliable Digit Span (RDS), an embedded performance validity test (PVT), is based on the highest number of digits correctly recalled in both forward and backward sequences from the Wechsler Memory Scale - Revised (WMS-R). An RDS score of 7 or lower has been proposed as a cut-off associated with suboptimal effort in neuropsychological assessment [44, 45]. PVTs are considered essential for verifying sufficient cognitive effort and a standard component of neuropsychological evaluations [46, 47]. Further details and results of the RDS are included in Additional File 2.
Data analysis
Statistical analyses were conducted using IBM SPSS version 29. An a-priori sample size calculation was conducted using G*Power for detecting group differences including three groups and age as a covariate. Assuming a medium effect size (f = 0.28), α = 0.05, and 80% power, the analysis indicated a required sample size of 126 participants. To compensate for screening failures and attrition, the recruitment target was increased to 150 participants (50 per group). Data were checked for errors, missing values, and outliers, with detailed procedures provided in Additional File 2. To maintain sample integrity, outliers were winsorized at the 5th and 95th percentiles [48].
Descriptive analyses included chi-square tests, t-tests, AN(C)OVA, and Kruskal-Wallis tests for sociodemographic and COVID-19-related variables. Correlations were assessed using Kendall’s Tau.
Linear mixed models (LMMs) were used to analyze effects of psychological burden and subjective complaints on verbal fluency across timepoints. Semantic and lexical fluency were examined separately, with Years of Education as a fixed covariate and random effects assigned to Subject and Intercept. Comorbidities were included as covariates only when their inclusion improved model fit. Age was initially included as a covariate but was not retained in the final models because it did not contribute meaningfully to the outcomes. Model fit was evaluated using Bayesian Information Criterion (BIC), and bootstrapping (1000 samples) addressed assumption violations. Effect sizes were reported as eta squared (η2) or Cramer’s V, and partial eta squared (ηp2) for LMMs. An alpha level of α = 0.05 was used for all analyses.
Results
Baseline data included 159 participants, with 124 completing the third visit (HC = 42, MLD = 37, SEV = 44), corresponding to dropout rates of 23.6% (n = 13), 28.8% (n = 15), and 15.4% (n = 8), respectively. Dropout did not differ significantly between the COVID-19 survivor and healthy control groups (χ² = 2.73, p = .254). Participants were aged 25 to 73 years, and 52.2% were female. Most had a university or college degree (44%) and were married (56%). The SEV group was significantly older than the MLD group. However, years of education and sex distribution did not differ significantly between groups. Additional demographic and clinical details, including group comparisons, are provided in Table 1. No participants were excluded from the analysis based on performance validity criteria.
Table 1Sociodemographic and clinical baseline characteristics
Characteristics HC(n = 55) MLD(n = 52) SEV(n = 52) Total sample(N = 159) p η2 / V
Age, years (M, SD) 47.09, 13.19 45.35, 12.24 51.25, 11.54 47.88, 12.52 0.046* 0.039
Female (n, %) 29, 52.7% 26, 50% 28, 53.8% 83, 52.2% 0.922 0.032
Education, years (M, SD) 15.83, 2.25 15.81, 2.87 15.54, 2.57 15.728, 2.36 0.781 0.003
NoC (median, IQR) 1,0–2 1,0–2 2,1–3.75 1,0–2 < 0.001*** 0.101
Days between positive COVID-19 test and visit 1, (M, SD) - 264.66, 146.821 325.5, 153.11 295.68, 152.412 0.043* 0.040
BMI (M, SD) 25.656, 4.494 26.048, 4.684 28.100, 6.158 26.584, 5.232 0.114 0.042
Note. BMI = Body Mass Index; HC = healthy controls, MLD = mild/asymptomatic, SEV = severe; NoC = Number of comorbidities; *p < .05, **p < .01, ***p < .001. Eta squared and Cramer’s V indicate effect sizes: small (η2 ≥ 0.01; V ≥ 0.1), moderate (η2 ≥ 0.06; V ≥ 0.3), or large (η2 ≥ 0.14; V ≥ 0.5) effects
Neuropsychological test and questionnaire results
Semantic Fluency differed between groups at the first visit (p < .001, η2 = 0.116). Tukey HSD post-hoc test revealed a significant difference (p < .001) between the HC- and the SEV-group as well as a significant difference (p = .025) between the MLD- and SEV-group. The average number of words per group was HC = 29, MLD = 26, SEV = 23. However, no significant group differences were observed at the third visit. No significant differences in lexical fluency were found between groups at either visit (see Fig. 1). A Kruskal-Wallis test indicated that there was a significant difference in ISR total score across groups at both visits (p < .001). The results for the ECog-12 total scores differed between group at both time points (p < .001). Post-hoc comparisons for ISR and ECog-12 revealed that the differences between all groups for all variables were significant at the p = .05 level. Additional File 3 provides the exact data and effect sizes. Additional File 4 provides mean scores and standard deviations of ISR, ECog-12, and verbal fluency measures at both visits, per group and for the total sample. It also reports age-adjusted ANCOVA results for the verbal fluency outcomes.
Correlation analysis of the relevant variables
To address the relationships between psychological burden, subjective complaints, and verbal fluency, key correlations are presented in Table 2. The correlational analyses confirmed that Group was significantly associated with Semantic Fluency, ISR, and ECog-12, indicating greater symptom severity in the SEV-group. Notably, Semantic Fluency was negatively correlated with both ISR and ECog-12 at both visits, while Lexical Fluency showed no significant associations with either measure. The complete correlation matrix is provided in Additional File 5.
Table 2Main Correlations (Kendall’s Tau) of Group, Semantic Fluency, ISR, and ECog-12
Variable Group SF V1 SF V3
ISR V1 0.340** − 0.193** − 0.148*
ISR V3 0.349** − 0.148* − 0.135*
ECog-12 V1 0.536** − 0.289** − 0.170*
ECog-12 V3 0.476** − 0.249** − 0.202*
Note. SF = Semantic Fluency, ISR = ICD-10 Symptom Rating Scale, ECog-12 = Everyday Cognition 12. *p < .05, **p < .01
Mixed model analyses
The main outcomes of the models are presented here. Additional File 6 provides an overview of the tested models and their BIC, Additional File 7 of all fixed effects, and Additional File 8 of the significant estimated fixed effects.
Model 1: linking COVID-19 burden levels to verbal ability
The best-fitting model for Semantic Fluency included Visit, Group, an interaction term (Visit × Group), Education Years, and Number of Comorbidities as fixed effects along with the specified random effects subject and intercept. The model explained a substantial proportion of variance (marginal R2 = 0.147, conditional pseudo R2 =0.710), while F-statistics for Group (p < .001, ηp2 = .111), Education Years (p < .001, ηp2 = 0.090), and Number of Comorbidities (p = .004, ηp2 = 0.057) were significant. Visit and the interaction term remained non-significant, indicating that while Group significantly affected Semantic Fluency, scores did not change significantly between the visits. Overall, Semantic Fluency was highest in the HC group, followed by MLD, with the SEV group showing the lowest performance across visits. Descriptively, the SEV group showed a non-significant increase in Semantic Fluency from Visit 1 (M = 23.29, SD = 6.12) to Visit 3 (M = 24.60, SD = 6.47). A separate model was fitted for Lexical Fluency. In contrast to the Semantic Fluency analysis, this model included Education Years as the only covariate, as additional covariates did not improve model fit. The model yielded a marginal R2 of 0.078 and a conditional pseudo R2 of 0.648. The significant F-statistics were those for Education Years (p = .003, ηp2 = 0.071) and the Visit x Group interaction (p = .049, ηp2 = 0.048). Group and Visit remained non-significant, suggesting no meaningful differences in Lexical Fluency scores between groups or across visits. However, the Visit 1 × HC interaction was significant (p = .037), indicating group-specific differences in change between these timepoints rather than a uniform pattern across all visits.
Model 2: linking psychological burden to verbal ability across COVID-19 burden levels
The final linear mixed-effects model for Semantic Fluency included Education and Comorbidities as covariates. The model yielded a marginal R2 of 0.216 and a conditional R2 of 0.716. Significant fixed effects were found for Group (p = .022, ηp2 = 0.034), ISR (p = .004, ηp2 = 0.031), Comorbidities (p < .001, ηp2 = 0.076), and Education Years (p < .001, ηp2 = 0.086). ISR showed a negative association with semantic fluency, with higher psychological burden corresponding to fewer produced words.
Regarding lexical fluency, the final model included Education Years as the only covariate, with a marginal R2 = 0.082 and conditional R2 = 0.645. It demonstrated a significant fixed effect of Education Years (p = .003, ηp2 = 0.072), while all other effects remained non-significant.
Model 3: linking subjective complaints to verbal ability across COVID-19 burden levels
Different model structures were selected for Semantic and Lexical Fluency based on model fit criteria. For Semantic Fluency, the best-fitting model included Visit, Group, ECog-12, their interactions, Education Years, and Number of Comorbidities as fixed effects. The model generated a marginal R2 of 0.210 and a conditional R2 of 0.724. Significant F-Statistics were found for the ECog-12 (p = .015, ηp2 = 0.022), Education Years (p < .001, ηp2 = 0.094), Comorbidities (p = .005, ηp2 = 0.056), and the Group × ECog-12 interaction (p = .012, ηp2 = 0.037).
For Lexical Fluency, the best-fitting model included Visit, Group, ECog-12, their interaction terms, and Education Years as fixed effects. The model generated a marginal R2 of 0.083 and a conditional R2 of 0.646. Significant effects were observed for Education Years (p = .002, ηp2 = 0.075) and the Visit × Group interaction (p = .030, ηp2 = 0.058). No significant effects were observed for ECog-12 or its interaction terms, suggesting that subjective cognitive complaints were not associated with lexical fluency performance over time.
Discussion
This study investigated the longitudinal verbal fluency performance over 12 months in COVID-19 survivors and healthy controls, focusing on the role of psychological burden and subjective cognitive complaints. The main findings of this study indicate a dissociation between semantic and lexical verbal fluency in their associations with COVID-19 burden, psychological distress, and subjective complaints. Specifically, semantic fluency was consistently associated with group status, psychological burden, subjective complaints, and comorbidities, whereas lexical fluency showed a more restricted pattern of associations, being primarily linked to educational attainment.
In line with our first hypothesis, semantic fluency performance differed across groups, with HC outperforming both COVID-19 groups and the SEV group showing the lowest overall performance. Importantly, these effects were largely stable over the 12-month period, with limited evidence for change across visits. Although not significant, the SEV-group showed a trend toward improvement, possibly reflecting regression to the mean or pandemic effects [12]. At the same time, the longitudinal trajectories observed in the healthy control group suggest that broader pandemic-related influences may also have contributed to cognitive performance over time. A significant Visit × Group (HC) interaction emerged for lexical fluency, indicating a slight decline in HC while COVID-19 groups remained stable. However, there were no significant main effects of Visit or Group, reflecting no robust longitudinal change or between-group differences in lexical fluency. The observed patterns align with Miskowiak et al. [7], who found cognitive sequelae to be stable for one year post-hospitalization.
However, these results should be interpreted cautiously, as the absence of pre-infection data precludes conclusions regarding whether these differences reflect consequences of COVID-19 severity, pre-existing group differences, or broader contextual factors related to the pandemic experience.
Partially in line with our second hypothesis, an association was found between psychological burden and semantic fluency, with higher psychological burden being associated with lower semantic fluency performance, consistent with prior studies [18, 30]. However, no such association was observed for lexical fluency. One possible explanation is that semantic fluency relies more strongly on efficient access to stored conceptual knowledge [37], which may be particularly vulnerable to the effects of stress, and reduced cognitive efficiency commonly reported in individuals experiencing elevated psychological burden [49]. LMM analyses did not identify interaction effects, possibly due to low ISR variance (i.e., low between-subject variance and limited spread across both groups and visits, with SDs of approximately 0.5 as reported in Additional File 4).
Regarding subjective cognitive complaints, results again demonstrated a selective association with semantic fluency. Higher self-reported cognitive difficulties were linked to poorer semantic fluency performance, with this relationship differing across COVID-19 groups (Group × ECog-12 interaction). Specifically, the HC and MLD groups differed significantly from the SEV group in this relationship, indicating that the association between subjective complaints and objective performance differed across groups. This partial convergence between subjective and objective cognition is consistent with the results of some studies [38, 50], but not with others [39]. Overall, the emergence of post-COVID-19 complaints likely reflects a multifactorial construct influenced not only by objective performance. From a biopsychosocial perspective, they may arise from the relationship between perceived cognitive change, emotional distress, health status, and individual differences [29,51, 52].
The differential pattern between semantic and lexical fluency suggests partially distinct cognitive mechanisms [37, 53]. While education predicted performance in both tasks, comorbidities were selectively associated with semantic fluency, potentially reflecting a stronger reliance on semantic knowledge systems that are more sensitive to global health status and cognitive reserve. In contrast, lexical fluency appears to depend more specifically on executive retrieval strategies, which may be less affected by medical burden. Additionally, the LMMs yielded an unexpected positive association between comorbidity burden and semantic fluency performance, which may reflect selection or care-related effects in this post-COVID sample. Greater healthcare contact or access to rehabilitation or compensatory strategies among individuals with higher medical burden could partly explain this association, rather than indicating a direct beneficial effect of comorbid conditions.
Furthermore, age may influence verbal fluency performance, particularly at older ages [54]. In our analyses, age was evaluated as a potential covariate but did not improve model fit and was therefore not retained in the final models. Age-adjusted ANCOVA results are provided in Additional File 4. Although age-related effects cannot be entirely excluded, the present analyses do not indicate that age accounts for the reported group pattern.
Across models, education emerged as a robust and consistent predictor of verbal fluency performance. Notably, it was the only variable consistently associated with lexical fluency, suggesting that lexical retrieval performance in this sample was primarily explained by educational attainment rather than COVID-19-related or psychological factors. This finding is consistent with the well-established role of education as an index of cognitive reserve and verbal proficiency [55, 56].
Practical implications
Semantic fluency is a short, cost-effective measure of verbal fluency. In this community-based sample, semantic fluency performance was associated with psychological burden and subjective cognitive complaints. The inclusion of actively recruited healthy controls is important when interpreting whether such differences may reflect COVID-19-related, pre-existing, or broader pandemic-contextual factors. Word-finding difficulties and brain fog are frequently reported by individuals recovering from COVID-19 and warrant consideration alongside objective cognitive performance and psychological burden. The present findings underscore the importance of including actively recruited control groups when attempting to distinguish disease-related effects from contextual influences. Word-finding difficulties and brain fog, frequently reported by individuals recovering from COVID-19, reflect real-life cognitive concerns [57]. Whether interventions targeting psychological burden alleviate cognitive challenges after COVID-19 requires prospective intervention studies. Evidence from stroke and cancer populations nevertheless suggests that this is a relevant question for future research [58, 59].
Implications for future pandemics/ endemics
With the increasing frequency of global epidemics [60, 61], these findings possibly extend beyond COVID-19 to other pandemics and endemics caused by viral or other infectious diseases. Similar cognitive and psychological impairments have been observed in SARS survivors [62, 63]. These parallels suggest that the interplay between psychological burden and cognitive function could potentially constitute a common feature of post-viral syndromes.
Interventions and future directions
Given the association between psychological distress and cognitive performance, psychoeducational or therapeutic interventions may help alleviate cognitive challenges. Research in other populations suggests that psychological interventions can improve cognitive function [58, 59, 64, 65]. Similar approaches may also benefit individuals recovering from COVID-19 by addressing the psychological factors underlying cognitive deficits [66].
Future research should further investigate mechanisms linking psychological burden, depressive symptomatology, subjective complaints, and cognitive impairments, considering variables such as cogniphobia [65], fatigue, demographic influences, and potential Long COVID subtypes [67]. Methodological limitations of self-report measures, particularly for psychological burden, should be considered, including response biases and state effects, with multi-method approaches improving assessment validity [68]. Additionally, examining the cumulative effects of psychological and biological factors, including cytokine storms or amyloid-β accumulation [69], may enhance our understanding of post-COVID-19 cognitive sequelae.
Limitations
A key limitation is the one-minute duration of verbal fluency tasks, which may have reduced sensitivity to mild deficits, as longer tasks (e.g., two minutes) are more effective in detecting subtle impairments. Additionally, only basic fluency was assessed, rather than a category-switching variant, which could have provided deeper insights into executive functions. However, the one-minute tasks were sufficiently sensitive to detect group differences and longitudinal changes in the present cohort. Nonetheless, these methodological aspects should be considered when interpreting the findings. Furthermore, our study did not include a global cognitive screening such as the MMSE or MoCA, limiting comparability with other studies. Importantly, the verbal fluency scores in the present study were analysed as raw performance measures and were not intended to establish clinical cognitive impairment. The observed group differences should therefore be interpreted as differences in verbal fluency performance rather than as evidence of clinically meaningful impairment.
In addition, a high percentage of participants in our study had higher levels of education compared to the general population, which may limit generalizability. Our participants may have increased cognitive reserve associated with higher education, potentially supporting compensatory strategies that could have attenuated observable cognitive differences in verbal fluency [56]. Additionally, although dropout did not differ between study groups, older participants were more likely to drop out by Visit 3, truncating our understanding of outcomes among older individuals. Since our sample comprised community-based volunteers rather than clinical cohorts seeking treatment for cognitive impairments following COVID-19, these results do not generalize to PCS populations. While our findings likely extend to individuals who have experienced COVID-19 in general, the extreme group comparison between mild and severe cases prevents us from confidently determining their applicability to the majority who had moderate, non-hospitalized courses. Differences in time since infection at baseline could not be modelled as a covariate because it was only available for COVID-19 participants, preventing its inclusion in between-group analyses. Furthermore, formal assessment according to established diagnostic criteria of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS) was not part of the study protocol, limiting conclusions regarding overlap between post-COVID cognitive symptoms and ME/CFS-related symptomatology.
Conclusion
In conclusion, cognitive outcomes following COVID-19 as operationalized by semantic fluency performance, were consistently associated not only with disease severity, but also psychological burden across the observation period. Importantly, subjective complaints were differentially associated with objective performance across groups, highlighting that their relationship to cognition is not uniform but context-sensitive. The present pattern of results suggests that semantic fluency appears to be particularly sensitive to a combination of psychological burden and overall health status, whereas lexical fluency is comparatively stable and more strongly related to educational attainment. These findings support a multifaceted assessment of post-COVID cognitive difficulties, including consideration of broader contextual influences, and underscore the limitations of relying on a single indicator. A combined assessment approach appears advantageous for identifying appropriate intervention targets. Verbal fluency tests and self-report measures—administrable via telehealth or telephone—may serve as efficient tools for triaging individuals in need of comprehensive neuropsychological evaluations when in-person visits are not feasible. Future research targeting this possibility is warranted. Lastly, recognizing the broader impact of societal and pandemic-related stressors, even among the healthy population, is crucial for distinguishing infection-related effects from broader contextual influences.
Supplementary Information
Below is the link to the electronic supplementary material.
References
1.Hu B Guo H Zhou P Shi ZL Characteristics of SARS-CoV-2 and COVID-19 Nat Rev Microbiol März 2021 19 3 141 54 10.1038/s41579-020-00459-7 PMC7537588 33024307 Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol März. 2021;19(3):141–54. 10.1038/s41579-020-00459-7 .PMC7537588 33024307
2.Miskowiak K Johnsen S Sattler S Nielsen S Kunalan K Rungby J u. a. Cognitive impairments four months after COVID-19 hospital discharge: Pattern, severity and association with illness variables Eur Neuropsychopharmacol Mai 2021 46 39 48 10.1016/j.euroneuro.2021.03.019 PMC8006192 33823427 Miskowiak K, Johnsen S, Sattler S, Nielsen S, Kunalan K, Rungby J. u. a. Cognitive impairments four months after COVID-19 hospital discharge: Pattern, severity and association with illness variables. Eur Neuropsychopharmacol Mai. 2021;46:39–48. 10.1016/j.euroneuro.2021.03.019 .PMC8006192 33823427
3.Vannorsdall TD Brigham E Fawzy A Raju S Gorgone A Pletnikova A u. a. Cognitive Dysfunction, Psychiatric Distress, and Functional Decline After COVID-19 J Acad Consult-Liaison Psychiatry März 2022 63 2 133 43 10.1016/j.jaclp.2021.10.006 PMC8591857 34793996 Vannorsdall TD, Brigham E, Fawzy A, Raju S, Gorgone A, Pletnikova A. u. a. Cognitive Dysfunction, Psychiatric Distress, and Functional Decline After COVID-19. J Acad Consult-Liaison Psychiatry März. 2022;63(2):133–43. 10.1016/j.jaclp.2021.10.006 .PMC8591857 34793996
4.Crivelli L Palmer K Calandri I Guekht A Beghi E Carroll W u. a. Changes in cognitive functioning after COVID-19: A systematic review and meta‐analysis Alzheimers Dement Mai 2022 18 5 1047 66 10.1002/alz.12644 PMC9073922 35297561 Crivelli L, Palmer K, Calandri I, Guekht A, Beghi E, Carroll W. u. a. Changes in cognitive functioning after COVID-19: A systematic review and meta‐analysis. Alzheimers Dement Mai. 2022;18(5):1047–66. 10.1002/alz.12644 .PMC9073922 35297561
5.Seibert S Hanke A Wieberneit M Bieler L Gräfenkämper R Klatt K u. a. What We Know About Neurocognitive Outcomes in Long-/Post-COVID-19 Adults: A Comprehensive Scoping Review Z Für Neuropsychol Mai 2024 35 2 63 76 10.1024/1016-264X/a000395 Seibert S, Hanke A, Wieberneit M, Bieler L, Gräfenkämper R, Klatt K. u. a. What We Know About Neurocognitive Outcomes in Long-/Post-COVID-19 Adults: A Comprehensive Scoping Review. Z Für Neuropsychol Mai. 2024;35(2):63–76. 10.1024/1016-264X/a000395 .
6.Poletti S Palladini M Mazza MG De Lorenzo R The COVID-19 BioB Outpatient Clinic Study groupIrene B u. a. Long-term consequences of COVID-19 on cognitive functioning up to 6 months after discharge: role of depression and impact on quality of life Eur Arch Psychiatry Clin Neurosci August 2022 272 5 773 82 10.1007/s00406-021-01346-9 PMC8546751 34698871 Poletti S, Palladini M, Mazza MG, De Lorenzo R, The COVID-19 BioB Outpatient Clinic Study group, Irene B. u. a. Long-term consequences of COVID-19 on cognitive functioning up to 6 months after discharge: role of depression and impact on quality of life. Eur Arch Psychiatry Clin Neurosci August. 2022;272(5):773–82. 10.1007/s00406-021-01346-9 .PMC8546751 34698871
7.Miskowiak K Fugledalen L Jespersen A Sattler S Podlekareva D Rungby J u. a. Trajectory of cognitive impairments over 1 year after COVID-19 hospitalisation: Pattern, severity, and functional implications Eur Neuropsychopharmacol Juni 2022 59 82 92 10.1016/j.euroneuro.2022.04.004 PMC9008126 35561540 Miskowiak K, Fugledalen L, Jespersen A, Sattler S, Podlekareva D, Rungby J. u. a. Trajectory of cognitive impairments over 1 year after COVID-19 hospitalisation: Pattern, severity, and functional implications. Eur Neuropsychopharmacol Juni. 2022;59:82–92. 10.1016/j.euroneuro.2022.04.004 .PMC9008126 35561540
8.Pihlaja RE Kauhanen LLS Ollila HS Tuulio-Henriksson AS Koskinen SK Tiainen M u. a. Associations of subjective and objective cognitive functioning after COVID-19: A six-month follow-up of ICU, ward, and home-isolated patients Brain Behav Immun - Health Februar 2023 27 100587 10.1016/j.bbih.2023.100587 PMC9812472 36624888 Pihlaja RE, Kauhanen LLS, Ollila HS, Tuulio-Henriksson AS, Koskinen SK, Tiainen M. u. a. Associations of subjective and objective cognitive functioning after COVID-19: A six-month follow-up of ICU, ward, and home-isolated patients. Brain Behav Immun - Health Februar. 2023;27:100587. 10.1016/j.bbih.2023.100587 .PMC9812472 36624888
9.World Health Organization (WHO). Post COVID-19 condition (Long COVID) [Internet]. 2022 [zitiert 10. Februar 2025]. Verfügbar unter: https://www.who.int/europe/news-room/fact-sheets/item/post-COVID-19-condition
10.Bandala C Cortes-Altamirano JL Reyes-Long S Lara-Padilla E Ilizaliturri-Flores I Alfaro-Rodríguez A Putative mechanism of neurological damage in COVID-19 infection Acta Neurobiol Exp (Warsz) 2021 81 1 69 79 10.21307/ane-2021-008 33949163 Bandala C, Cortes-Altamirano JL, Reyes-Long S, Lara-Padilla E, Ilizaliturri-Flores I, Alfaro-Rodríguez A. Putative mechanism of neurological damage in COVID-19 infection. Acta Neurobiol Exp (Warsz). 2021;81(1):69–79. 10.21307/ane-2021-008 .33949163
11.García-Sánchez C Calabria M Grunden N Pons C Arroyo JA Gómez-Anson B u. a. Neuropsychological deficits in patients with cognitive complaints after COVID-19 Brain Behav März 2022 12 3 e2508 2508 PubMed PMID: 35137561; PubMed Central PMCID: PMC893377910.1002/brb3 PMC8933779 35137561 García-Sánchez C, Calabria M, Grunden N, Pons C, Arroyo JA, Gómez-Anson B. u. a. Neuropsychological deficits in patients with cognitive complaints after COVID-19. Brain Behav März. 2022;12(3):e2508. 10.1002/brb3 . 2508 PubMed PMID: 35137561; PubMed Central PMCID: PMC8933779.PMC8933779 35137561
12.Widmann CN Kolano J Peper M Improving Neuropsychological Rehabilitation for COVID-19 Patients: Guideline-Based Advances Z Für Neuropsychol Juni 2023 34 2 57 70 10.1024/1016-264X/a000373 Widmann CN, Kolano J, Peper M. Improving Neuropsychological Rehabilitation for COVID-19 Patients: Guideline-Based Advances. Z Für Neuropsychol Juni. 2023;34(2):57–70. 10.1024/1016-264X/a000373 .
13.Badinlou F Lundgren T Jansson-Fröjmark M Mental health outcomes following COVID-19 infection: impacts of post-COVID impairments and fatigue on depression, anxiety, and insomnia — a web survey in Sweden BMC Psychiatry 29 November 2022 22 1 743 10.1186/s12888-022-04405-0 PMC9708120 36447183 Badinlou F, Lundgren T, Jansson-Fröjmark M. Mental health outcomes following COVID-19 infection: impacts of post-COVID impairments and fatigue on depression, anxiety, and insomnia — a web survey in Sweden. BMC Psychiatry 29 November. 2022;22(1):743. 10.1186/s12888-022-04405-0 .PMC9708120 36447183
14.Khraisat B Toubasi A AlZoubi L Al-Sayegh T Mansour A Meta-analysis of prevalence: the psychological sequelae among COVID-19 survivors Int J Psychiatry Clin Pract 1 September 2022 26 3 234 43 10.1080/13651501.2021.1993924 34709105 Khraisat B, Toubasi A, AlZoubi L, Al-Sayegh T, Mansour A. Meta-analysis of prevalence: the psychological sequelae among COVID-19 survivors. Int J Psychiatry Clin Pract 1 September. 2022;26(3):234–43. 10.1080/13651501.2021.1993924 .34709105
15.Mazza MG De Lorenzo R Conte C Poletti S Vai B Bollettini I, u. a. Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors Brain Behav Immun Oktober 2020 89 594 600 10.1016/j.bbi.2020.07.037 PMC7390748 32738287 Mazza MG, De Lorenzo R, Conte C, Poletti S, Vai B. Bollettini I, u. a. Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain Behav Immun Oktober. 2020;89:594–600. 10.1016/j.bbi.2020.07.037 .PMC7390748 32738287
16.Klinkhammer S Horn J Duits AA Visser-Meily JMA Verwijk E Slooter AJC u. a. Neurological and (neuro)psychological sequelae in intensive care and general ward COVID ‐19 survivors Eur J Neurol Juli 2023 30 7 1880 90 10.1111/ene.15812 37010152 Klinkhammer S, Horn J, Duits AA, Visser-Meily JMA, Verwijk E, Slooter AJC. u. a. Neurological and (neuro)psychological sequelae in intensive care and general ward COVID ‐19 survivors. Eur J Neurol Juli. 2023;30(7):1880–90. 10.1111/ene.15812 .37010152
17.Brown RG Scott LC Bench CJ Dolan RJ Cognitive function in depression: its relationship to the presence and severity of intellectual decline Psychol Med November 1994 24 4 829 47 10.1017/S0033291700028932 7892352 Brown RG, Scott LC, Bench CJ, Dolan RJ. Cognitive function in depression: its relationship to the presence and severity of intellectual decline. Psychol Med November. 1994;24(4):829–47. 10.1017/S0033291700028932 .7892352
18.Brown LA Ballentine E Zhu Y McGinley EL Pezzin L Abramoff B The unique contribution of depression to cognitive impairment in Post-Acute Sequelae of SARS-CoV-2 infection Brain Behav Immun - Health Juli 2022 22 100460 10.1016/j.bbih.2022.100460 PMC8983478 35403066 Brown LA, Ballentine E, Zhu Y, McGinley EL, Pezzin L, Abramoff B. The unique contribution of depression to cognitive impairment in Post-Acute Sequelae of SARS-CoV-2 infection. Brain Behav Immun - Health Juli. 2022;22:100460. 10.1016/j.bbih.2022.100460 .PMC8983478 35403066
19.Dafsari FS Jessen F Depression—an underrecognized target for prevention of dementia in Alzheimer’s disease Transl Psychiatry 20 Mai 2020 10 1 160 10.1038/s41398-020-0839-1 PMC7239844 32433512 Dafsari FS, Jessen F. Depression—an underrecognized target for prevention of dementia in Alzheimer’s disease. Transl Psychiatry 20 Mai. 2020;10(1):160. 10.1038/s41398-020-0839-1 .PMC7239844 32433512
20.Jorm AF Is Depression a Risk Factor for Dementia or Cognitive Decline? Gerontology 2000 46 4 219 27 10.1159/000022163 10859462 Jorm AF. Is Depression a Risk Factor for Dementia or Cognitive Decline? Gerontology. 2000;46(4):219–27. 10.1159/000022163 .10859462
21.Klinkhammer S Duits AA Deckers K Horn J Slooter AJC Verwijk E u. a. A Biopsychosocial Approach to Persistent Post-COVID-19 Fatigue and Cognitive Complaints: Results of the Prospective Multicenter NeNeSCo Study Arch Phys Med Rehabil Mai 2024 105 5 826 34 10.1016/j.apmr.2023.12.014 38228250 Klinkhammer S, Duits AA, Deckers K, Horn J, Slooter AJC, Verwijk E. u. a. A Biopsychosocial Approach to Persistent Post-COVID-19 Fatigue and Cognitive Complaints: Results of the Prospective Multicenter NeNeSCo Study. Arch Phys Med Rehabil Mai. 2024;105(5):826–34. 10.1016/j.apmr.2023.12.014 .38228250
22.Pietrabissa G Simpson SG Psychological Consequences of Social Isolation During COVID-19 Outbreak Front Psychol 9 September 2020 11 2201 10.3389/fpsyg.2020.02201 PMC7513674 33013572 Pietrabissa G, Simpson SG. Psychological Consequences of Social Isolation During COVID-19 Outbreak. Front Psychol 9 September. 2020;11:2201. 10.3389/fpsyg.2020.02201 .PMC7513674 33013572
23.Wolf K Schmitz J Scoping review: longitudinal effects of the COVID-19 pandemic on child and adolescent mental health Eur Child Adolesc Psychiatry Mai 2024 33 5 1257 312 10.1007/s00787-023-02206-8 PMC10119016 37081139 Wolf K, Schmitz J. Scoping review: longitudinal effects of the COVID-19 pandemic on child and adolescent mental health. Eur Child Adolesc Psychiatry Mai. 2024;33(5):1257–312. 10.1007/s00787-023-02206-8 .PMC10119016 37081139
24.Giannouli V, Giannoulis K. Better Understand to Better Predict Subjective Well-Being Among Older Greeks in COVID-19 Era: Depression, Anxiety, Attitudes Towards eHealth, Religiousness, Spiritual Experience, and Cognition. In: Vlamos P, editor. Herausgeber. GeNeDis 2022 [Internet]. Advances in Experimental Medicine and Biology. Cham: Springer International Publishing; 2023. pp. 359–64. [zitiert 9. Juni 2026]. https://link.springer.com/. . Verfügbar unter.10.1007/978-3-031-31986-0_35 37581810
25.Santomauro DF Miller PA Shadid J Wulf Hanson S Vo A Roy DJ u. a. Updated trends in the global prevalence and burden of mental disorders, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 Lancet Mai 2026 407 10543 2040 64 10.1016/S0140-6736(26)00519-2 42167272 Santomauro DF, Miller PA, Shadid J, Wulf Hanson S, Vo A, Roy DJ. u. a. Updated trends in the global prevalence and burden of mental disorders, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet Mai. 2026;407(10543):2040–64. 10.1016/S0140-6736(26)00519-2 .42167272
26.Ingram J Hand CJ Maciejewski G Social isolation during COVID -19 lockdown impairs cognitive function Appl Cogn Psychol Juli 2021 35 4 935 47 10.1002/acp.3821 PMC8250848 34230768 Ingram J, Hand CJ, Maciejewski G. Social isolation during COVID -19 lockdown impairs cognitive function. Appl Cogn Psychol Juli. 2021;35(4):935–47. 10.1002/acp.3821 .PMC8250848 34230768
27.Tragantzopoulou P Giannouli V Social isolation and loneliness in old age: Exploring their role in mental and physical health Psychiatriki 2021 10.22365/jpsych.2021.009 33759810 Tragantzopoulou P, Giannouli V. Social isolation and loneliness in old age: Exploring their role in mental and physical health. Psychiatriki. 2021. 10.22365/jpsych.2021.009 .33759810
28.Aretouli E Malik M Widmann C Parker AM Oh ES Vannorsdall TD Cognitive and mental health outcomes in long covid BMJ 16 Juli 2025 390 e081349 10.1136/bmj-2024-081349 40670058 Aretouli E, Malik M, Widmann C, Parker AM, Oh ES, Vannorsdall TD. Cognitive and mental health outcomes in long covid. BMJ 16 Juli. 2025;390:e081349. 10.1136/bmj-2024-081349 .40670058
29.Delgado-Alonso C Díez‐Cirarda M Pagán J Pérez‐Izquierdo C Oliver‐Mas S Fernández‐Romero L u. a. Unraveling brain fog in post‐COVID syndrome: Relationship between subjective cognitive complaints and cognitive function, fatigue, and neuropsychiatric symptoms Eur J Neurol Januar 2025 32 1 e16084 10.1111/ene.16084 PMC11618112 37797297 Delgado-Alonso C, Díez‐Cirarda M, Pagán J, Pérez‐Izquierdo C, Oliver‐Mas S, Fernández‐Romero L. u. a. Unraveling brain fog in post‐COVID syndrome: Relationship between subjective cognitive complaints and cognitive function, fatigue, and neuropsychiatric symptoms. Eur J Neurol Januar. 2025;32(1):e16084. 10.1111/ene.16084 .PMC11618112 37797297
30.Mazza MG Palladini M De Lorenzo R Magnaghi C Poletti S Furlan R u. a. Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: Effect of inflammatory biomarkers at three-month follow-up Brain Behav Immun Mai 2021 94 138 47 10.1016/j.bbi.2021.02.021 PMC7903920 33639239 Mazza MG, Palladini M, De Lorenzo R, Magnaghi C, Poletti S, Furlan R. u. a. Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: Effect of inflammatory biomarkers at three-month follow-up. Brain Behav Immun Mai. 2021;94:138–47. 10.1016/j.bbi.2021.02.021 .PMC7903920 33639239
31.Shao Z, Janse E, Visser K, Meyer AS. What do verbal fluency tasks measure? Predictors of verbal fluency performance in older adults. Front Psychol 22 Juli. 2014;5. 10.3389/fpsyg.2014.00772 .PMC4106453 25101034
32.Poletti S Palladini M Mazza MG De Lorenzo R COVID-19 BioB Outpatient Clinic Study groupFurlan R u. a. Long-term consequences of COVID-19 on cognitive functioning up to 6 months after discharge: role of depression and impact on quality of life Eur Arch Psychiatry Clin Neurosci August 2022 272 5 773 82 PubMed PMID: 34698871; PubMed Central PMCID: PMC854675110.1007/s00406-021-01346-9 PMC8546751 34698871 Poletti S, Palladini M, Mazza MG, De Lorenzo R, COVID-19 BioB Outpatient Clinic Study group, Furlan R. u. a. Long-term consequences of COVID-19 on cognitive functioning up to 6 months after discharge: role of depression and impact on quality of life. Eur Arch Psychiatry Clin Neurosci August. 2022;272(5):773–82. 10.1007/s00406-021-01346-9 . PubMed PMID: 34698871; PubMed Central PMCID: PMC8546751.PMC8546751 34698871
33.Abrahams S Goldstein LH Simmons A Brammer MJ Williams SCR Giampietro VP u. a. Functional magnetic resonance imaging of verbal fluency and confrontation naming using compressed image acquisition to permit overt responses Hum Brain Mapp September 2003 20 1 29 40 10.1002/hbm.10126 PMC6872028 12953304 Abrahams S, Goldstein LH, Simmons A, Brammer MJ, Williams SCR, Giampietro VP. u. a. Functional magnetic resonance imaging of verbal fluency and confrontation naming using compressed image acquisition to permit overt responses. Hum Brain Mapp September. 2003;20(1):29–40. 10.1002/hbm.10126 .PMC6872028 12953304
34.Ariza M Cano N Segura B Adan A Bargalló N Caldú X u. a. COVID-19 severity is related to poor executive function in people with post-COVID conditions J Neurol Mai 2023 270 5 2392 408 10.1007/s00415-023-11587-4 PMC10026205 36939932 Ariza M, Cano N, Segura B, Adan A, Bargalló N, Caldú X. u. a. COVID-19 severity is related to poor executive function in people with post-COVID conditions. J Neurol Mai. 2023;270(5):2392–408. 10.1007/s00415-023-11587-4 .PMC10026205 36939932
35.Liu YH Chen Y Wang QH Wang LR Jiang L Yang Y u. a. One-Year Trajectory of Cognitive Changes in Older Survivors of COVID-19 in Wuhan, China: A Longitudinal Cohort Study JAMA Neurol 1 Mai 2022 79 5 509 10.1001/jamaneurol.2022.0461 PMC8905512 35258587 Liu YH, Chen Y, Wang QH, Wang LR, Jiang L, Yang Y. u. a. One-Year Trajectory of Cognitive Changes in Older Survivors of COVID-19 in Wuhan, China: A Longitudinal Cohort Study. JAMA Neurol 1 Mai. 2022;79(5):509. 10.1001/jamaneurol.2022.0461 .PMC8905512 35258587
36.Poletti S Palladini M Mazza MG De Lorenzo R The COVID-19 BioB Outpatient Clinic Study groupIrene B u. a. Long-term consequences of COVID-19 on cognitive functioning up to 6 months after discharge: role of depression and impact on quality of life Eur Arch Psychiatry Clin Neurosci August 2022 272 5 773 82 10.1007/s00406-021-01346-9 PMC8546751 34698871 Poletti S, Palladini M, Mazza MG, De Lorenzo R, The COVID-19 BioB Outpatient Clinic Study group, Irene B. u. a. Long-term consequences of COVID-19 on cognitive functioning up to 6 months after discharge: role of depression and impact on quality of life. Eur Arch Psychiatry Clin Neurosci August. 2022;272(5):773–82. 10.1007/s00406-021-01346-9 .PMC8546751 34698871
37.Henry JD Crawford JR A Meta-Analytic Review of Verbal Fluency Deficits in Depression J Clin Exp Neuropsychol 23 Februar 2005 27 1 78 101 10.1080/138033990513654 15814444 Henry JD, Crawford JR. A Meta-Analytic Review of Verbal Fluency Deficits in Depression. J Clin Exp Neuropsychol 23 Februar. 2005;27(1):78–101. 10.1080/138033990513654 .15814444
38.Goldstein FC Hajjar I Summers A Truong AD Lee FFEH Han JE u. a. Frequency and correlates of subjective cognitive complaints and objective cognitive screening results in African American adults following COVID-19 infection Brain Behav Immun - Health Dezember 2023 34 100691 10.1016/j.bbih.2023.100691 PMC10569942 37842136 Goldstein FC, Hajjar I, Summers A, Truong AD, Lee FFEH, Han JE. u. a. Frequency and correlates of subjective cognitive complaints and objective cognitive screening results in African American adults following COVID-19 infection. Brain Behav Immun - Health Dezember. 2023;34:100691. 10.1016/j.bbih.2023.100691 .PMC10569942 37842136
39.Hughes AJ, Bhattarai J (Jackie), Paul S, Beier M, editors. Depressive symptoms and fatigue as predictors of objective-subjective discrepancies in cognitive function in multiple sclerosis. Mult Scler Relat Disord. Mai 2019;30:192–7. 10.1016/j.msard.2019.01.055 PMC7282884 30797133
40.Widmann CN Wieberneit M Bieler L Bernsen S Gräfenkämper R Brosseron F u. a. Longitudinal Neurocognitive and Pulmonological Profile of Long COVID-19: Protocol for the COVIMMUNE-Clin Study JMIR Res Protoc 11 November 2021 10 11 e30259 10.2196/30259 PMC8589042 34559059 Widmann CN, Wieberneit M, Bieler L, Bernsen S, Gräfenkämper R, Brosseron F. u. a. Longitudinal Neurocognitive and Pulmonological Profile of Long COVID-19: Protocol for the COVIMMUNE-Clin Study. JMIR Res Protoc 11 November. 2021;10(11):e30259. 10.2196/30259 .PMC8589042 34559059
41.Jahn T, Heßler JB. Handanweisung Kognitive Funktionen Demenz. 2nd ed. SCHUHFRIED GmbH; 2019.
42.Tritt K, Von Heymann F, Zaudig M, Probst T, Loew T, Klapp B. u. a. Kurzbeschreibung ISR ICD-10-Symptom-Rating. 1st ed. SCHUHFRIED GmbH; 2018.
43.Tomaszewski Farias S Mungas D Harvey DJ Simmons A Reed BR DeCarli C The measurement of everyday cognition: Development and validation of a short form of the Everyday Cognition scales Alzheimers Dement November 2011 7 6 593 601 10.1016/j.jalz.2011.02.007 PMC3211103 22055976 Tomaszewski Farias S, Mungas D, Harvey DJ, Simmons A, Reed BR, DeCarli C. The measurement of everyday cognition: Development and validation of a short form of the Everyday Cognition scales. Alzheimers Dement November. 2011;7(6):593–601. 10.1016/j.jalz.2011.02.007 .PMC3211103 22055976
44.Ylioja SG Baird AD Podell K Developing a Spatial Analogue of the Reliable Digit Span Arch Clin Neuropsychol 1 Dezember 2009 24 8 729 39 10.1093/arclin/acp078 19854719 Ylioja SG, Baird AD, Podell K. Developing a Spatial Analogue of the Reliable Digit Span. Arch Clin Neuropsychol 1 Dezember. 2009;24(8):729–39. 10.1093/arclin/acp078 .19854719
45.Greiffenstein MF Baker WJ Gola T Validation of malingered amnesia measures with a large clinical sample Psychol Assess 1994 6 3 218 24 10.1037/1040-3590.6.3.218 Greiffenstein MF, Baker WJ, Gola T. Validation of malingered amnesia measures with a large clinical sample. Psychol Assess. 1994;6(3):218–24. 10.1037/1040-3590.6.3.218 .
46.McWhirter L Ritchie CW Stone J Carson A Performance validity test failure in clinical populations—a systematic review J Neurol Neurosurg Psychiatry September 2020 91 9 945 52 10.1136/jnnp-2020-323776 32651247 McWhirter L, Ritchie CW, Stone J, Carson A. Performance validity test failure in clinical populations—a systematic review. J Neurol Neurosurg Psychiatry September. 2020;91(9):945–52. 10.1136/jnnp-2020-323776 .32651247
47.Young JC Sawyer RJ Roper BL Baughman BC Expansion and Re-examination of Digit Span Effort Indices on the WAIS-IV Clin Neuropsychol Januar 2012 26 1 147 59 10.1080/13854046.2011.647083 22268525 Young JC, Sawyer RJ, Roper BL, Baughman BC. Expansion and Re-examination of Digit Span Effort Indices on the WAIS-IV. Clin Neuropsychol Januar. 2012;26(1):147–59. 10.1080/13854046.2011.647083 .22268525
48.Field A. Discovering statistics using IBM SPSS statistics. 5th edition. Los Angeles London New Delhi Singapore Washington DC Melbourne: SAGE; 2018. 1070 S. (SAGE edge).
49.Iosifescu DV The relation between mood, cognition and psychosocial functioning in psychiatric disorders Eur Neuropsychopharmacol Januar 2012 22 S499 504 10.1016/j.euroneuro.2012.08.002 22959115 Iosifescu DV. The relation between mood, cognition and psychosocial functioning in psychiatric disorders. Eur Neuropsychopharmacol Januar. 2012;22:S499–504. 10.1016/j.euroneuro.2012.08.002 .22959115
50.Schild AK Goereci Y Scharfenberg D Klein K Lülling J Meiberth D u. a. Multidomain cognitive impairment in non-hospitalized patients with the post-COVID-19 syndrome: results from a prospective monocentric cohort J Neurol März 2023 270 3 1215 23 10.1007/s00415-022-11444-w PMC9686246 36422669 Schild AK, Goereci Y, Scharfenberg D, Klein K, Lülling J, Meiberth D. u. a. Multidomain cognitive impairment in non-hospitalized patients with the post-COVID-19 syndrome: results from a prospective monocentric cohort. J Neurol März. 2023;270(3):1215–23. 10.1007/s00415-022-11444-w .PMC9686246 36422669
51.O’Shea DM De Wit L Szymkowicz SM McLaren ME Talty F Dotson VM Anxiety Modifies the Association between Fatigue and Verbal Fluency in Cognitively Normal Adults Arch Clin Neuropsychol 2016 6 September acn acwv0451 10.1093/arclin/acw045 PMC5860016 27600443 O’Shea DM, De Wit L, Szymkowicz SM, McLaren ME, Talty F, Dotson VM. Anxiety Modifies the Association between Fatigue and Verbal Fluency in Cognitively Normal Adults. Arch Clin Neuropsychol. 2016;6(September):acn–acwv0451. 10.1093/arclin/acw045 .PMC5860016 27600443
52.Klinkhammer S Duits AA Deckers K Horn J Slooter AJC Verwijk E u. a. A Biopsychosocial Approach to Persistent Post-COVID-19 Fatigue and Cognitive Complaints: Results of the Prospective Multicenter NeNeSCo Study Arch Phys Med Rehabil Mai 2024 105 5 826 34 10.1016/j.apmr.2023.12.014 38228250 Klinkhammer S, Duits AA, Deckers K, Horn J, Slooter AJC, Verwijk E. u. a. A Biopsychosocial Approach to Persistent Post-COVID-19 Fatigue and Cognitive Complaints: Results of the Prospective Multicenter NeNeSCo Study. Arch Phys Med Rehabil Mai. 2024;105(5):826–34. 10.1016/j.apmr.2023.12.014 .38228250
53.Wright LM, De Marco M, Venneri A. Current Understanding of Verbal Fluency in Alzheimer’s Disease: Evidence to Date. Psychol Res Behav Manag Mai 2023;Volume 16:1691–705. 10.2147/PRBM.S284645 PMC10167999 37179686
54.Rodriguez-Aranda C Martinussen M Age-Related Differences in Performance of Phonemic Verbal Fluency Measured by Controlled Oral Word Association Task (COWAT): A Meta-Analytic Study Dev Neuropsychol Oktober 2006 30 2 697 717 10.1207/s15326942dn3002_3 16995832 Rodriguez-Aranda C, Martinussen M. Age-Related Differences in Performance of Phonemic Verbal Fluency Measured by Controlled Oral Word Association Task (COWAT): A Meta-Analytic Study. Dev Neuropsychol Oktober. 2006;30(2):697–717. 10.1207/s15326942dn3002_3 .16995832
55.Nogueira J Gerardo B Santana I Simões MR Freitas S The Assessment of Cognitive Reserve: A Systematic Review of the Most Used Quantitative Measurement Methods of Cognitive Reserve for Aging Front Psychol 31 März 2022 13 847186 10.3389/fpsyg.2022.847186 PMC9023121 35465541 Nogueira J, Gerardo B, Santana I, Simões MR, Freitas S. The Assessment of Cognitive Reserve: A Systematic Review of the Most Used Quantitative Measurement Methods of Cognitive Reserve for Aging. Front Psychol 31 März. 2022;13:847186. 10.3389/fpsyg.2022.847186 .PMC9023121 35465541
56.Tremblay P Gagnon L Durand E Macoir J Exploring Factors Affecting Verbal Fluency in Healthy Aging Ann N Y Acad Sci November 2025 1553 1 319 33 10.1111/nyas.70064 PMC12645258 40974549 Tremblay P, Gagnon L, Durand E, Macoir J. Exploring Factors Affecting Verbal Fluency in Healthy Aging. Ann N Y Acad Sci November. 2025;1553(1):319–33. 10.1111/nyas.70064 .PMC12645258 40974549
57.Nouraeinejad A Brain fog as a Long-term Sequela of COVID-19. SN Compr Clin Med 24 November 2022 5 1 9 10.1007/s42399-022-01352-5 PMC9685075 36466122 Nouraeinejad A. Brain fog as a Long-term Sequela of COVID-19. SN Compr Clin Med. 24 November. 2022;5(1):9. 10.1007/s42399-022-01352-5 .PMC9685075 36466122
58.King S, Green HJ. Psychological Intervention for Improving Cognitive Function in Cancer Survivors: A Literature Review and Randomized Controlled Trial. Front Oncol 25 März. 2015;5. 10.3389/fonc.2015.00072 .PMC4373254 25859431
59.Merriman NA Sexton E McCabe G Walsh ME Rohde D Gorman A u. a. Addressing cognitive impairment following stroke: systematic review and meta-analysis of non-randomised controlled studies of psychological interventions BMJ Open Februar 2019 9 2 e024429 10.1136/bmjopen-2018-024429 PMC6398645 30819706 Merriman NA, Sexton E, McCabe G, Walsh ME, Rohde D, Gorman A. u. a. Addressing cognitive impairment following stroke: systematic review and meta-analysis of non-randomised controlled studies of psychological interventions. BMJ Open Februar. 2019;9(2):e024429. 10.1136/bmjopen-2018-024429 .PMC6398645 30819706
60.Marani M Katul GG Pan WK Parolari AJ Intensity and frequency of extreme novel epidemics Proc Natl Acad Sci 31 August 2021 118 35 e2105482118 10.1073/pnas.2105482118 PMC8536331 34426498 Marani M, Katul GG, Pan WK, Parolari AJ. Intensity and frequency of extreme novel epidemics. Proc Natl Acad Sci 31 August. 2021;118(35):e2105482118. 10.1073/pnas.2105482118 .PMC8536331 34426498
61.Meadows AJ Stephenson N Madhav NK Oppenheim B Historical trends demonstrate a pattern of increasingly frequent and severe spillover events of high-consequence zoonotic viruses BMJ Glob Health November 2023 8 11 e012026 10.1136/bmjgh-2023-012026 PMC10626885 37918874 Meadows AJ, Stephenson N, Madhav NK, Oppenheim B. Historical trends demonstrate a pattern of increasingly frequent and severe spillover events of high-consequence zoonotic viruses. BMJ Glob Health November. 2023;8(11):e012026. 10.1136/bmjgh-2023-012026 .PMC10626885 37918874
62.Kwek SK Chew WM Ong KC Ng AWK Lee LSU Kaw G u. a. Quality of life and psychological status in survivors of severe acute respiratory syndrome at 3 months postdischarge J Psychosom Res Mai 2006 60 5 513 9 10.1016/j.jpsychores.2005.08.020 PMC7094294 16650592 Kwek SK, Chew WM, Ong KC, Ng AWK, Lee LSU, Kaw G. u. a. Quality of life and psychological status in survivors of severe acute respiratory syndrome at 3 months postdischarge. J Psychosom Res Mai. 2006;60(5):513–9. 10.1016/j.jpsychores.2005.08.020 .PMC7094294 16650592
63.Lee AM Wong JG McAlonan GM Cheung V Cheung C Sham PC u. a. Stress and Psychological Distress among SARS Survivors 1 Year after the Outbreak Can J Psychiatry April 2007 52 4 233 40 10.1177/070674370705200405 17500304 Lee AM, Wong JG, McAlonan GM, Cheung V, Cheung C, Sham PC. u. a. Stress and Psychological Distress among SARS Survivors 1 Year after the Outbreak. Can J Psychiatry April. 2007;52(4):233–40. 10.1177/070674370705200405 .17500304
64.Jaleel A Farid G Irfan H Mahmood K Baig S A Systematic Review on the Mental Health Status of Patients Infected With Monkeypox Virus J Korean Acad Child Adolesc Psychiatry 1 April 2024 35 2 107 18 10.5765/jkacap.230064 PMC11001497 38601106 Jaleel A, Farid G, Irfan H, Mahmood K, Baig S. A Systematic Review on the Mental Health Status of Patients Infected With Monkeypox Virus. J Korean Acad Child Adolesc Psychiatry 1 April. 2024;35(2):107–18. 10.5765/jkacap.230064 .PMC11001497 38601106
65.Buzzanca-Fried KE, Snyder AR, Bauer RM, Morgan-Daniel J, De Corcho CP, Addeo R. u. a. Psychological Constructs From the Fear Avoidance Model and Beyond as Predictors for Persisting Symptoms After Concussion: An Integrative Review. Arch Phys Med Rehabil April. 2024;S0003999324009493. 10.1016/j.apmr.2024.04.007 .38663576
66.Cabello Fernandez C Didone V Lesoinne A Slama H Fery P Rousseau AF u. a. Cognitive and affective psychoeducation for Long COVID: a randomized controlled trial Brain Commun 30 Oktober 2025 7 6 fcaf447 10.1093/braincomms/fcaf447 PMC12631555 41277895 Cabello Fernandez C, Didone V, Lesoinne A, Slama H, Fery P, Rousseau AF. u. a. Cognitive and affective psychoeducation for Long COVID: a randomized controlled trial. Brain Commun 30 Oktober. 2025;7(6):fcaf447. 10.1093/braincomms/fcaf447 .PMC12631555 41277895
67.Wang B Luo X Wu M Wang Z Zhang J Wang Z u. a. Identifying subtypes of Long COVID: a systematic review eClinicalMedicine Januar 2026 91 103705 10.1016/j.eclinm.2025.103705 PMC12774694 41509610 Wang B, Luo X, Wu M, Wang Z, Zhang J, Wang Z. u. a. Identifying subtypes of Long COVID: a systematic review. eClinicalMedicine Januar. 2026;91:103705. 10.1016/j.eclinm.2025.103705 .PMC12774694 41509610
68.Meyer GJ Finn SE Eyde LD Kay GG Moreland KL Dies RR u. a. Psychological testing and psychological assessment: A review of evidence and issues Am Psychol Februar 2001 56 2 128 65 10.1037/0003-066X.56.2.128 11279806 Meyer GJ, Finn SE, Eyde LD, Kay GG, Moreland KL, Dies RR. u. a. Psychological testing and psychological assessment: A review of evidence and issues. Am Psychol Februar. 2001;56(2):128–65. 10.1037/0003-066X.56.2.128 .11279806
69.Hadad R Khoury J Stanger C Fisher T Schneer S Ben-Hayun R , u. a. Cognitive dysfunction following COVID-19 infection J Neurovirol Juni 2022 28 3 430 7 10.1007/s13365-022-01079-y PMC9134977 35618983 Hadad R, Khoury J, Stanger C, Fisher T, Schneer S, Ben-Hayun R., u. a. Cognitive dysfunction following COVID-19 infection. J Neurovirol Juni. 2022;28(3):430–7. 10.1007/s13365-022-01079-y .PMC9134977 35618983
Come citare questo studio
Kauffmann V, Seibert S, Heneka M, Rüsseler J, Widmann CN. (2026). Psychological burden, subjective complaints and their impact on the progression of verbal fluency in COVID-19 survivors and healthy controls: a longitudinal analysis.. BMC psychology. DOI: 10.1186/s40359-026-05929-w
Consulta la pubblicazione originale ↗